6th Drug Formulation, Solubility & Bioavailability Summit

Date: 27-Mar-17 to 29-Mar-17
Location: Hilton Boston Back Bay / Boston / United States
Category: Healthcare & Pharmaceuticals Conferences & Trade Fairs

Many of the industry’s early prospective methods for improving drug solubility have not succeeded at market. Increasingly, formulation professionals must specialize in developing amorphous solid dispersions, hot melt extrusions and spray-dried formulations. But an unexamined factor behind all of this is how biopharma companies should set and modify their formulation strategies in the first place.

Now in its sixth year, the Drug Formulation, Solubility & Bioavailability Summit continues to offer you the best learning and networking venue for improving drug performance and therapeutic impact through enabled formulations and more effective delivery methods. This year’s program features an all-new focus on underlying materials science and modeling questions that enable you to set a more successful strategy for your pipeline so you can be first to market!


Yi Gao, Stefan Proniuk, Sree Nadkarni, Keith Horspool, Rashmi Nair, Hannah Yu, Nikolay Zaborenko, Evan Thackaberry, Karthik Nagapudi, Sefan Yohe, Richard DiCicco, Miles Miller, Justin Mosesr, Amanda Mann, Susan Ciotti, Stephanie Dodd, Manuel Sanchez-Felix, Jaymin Shah, Fady Ibrahim, Yan He, Boris Shekunov, Khushboo Kothari, Eric Munson, Sean Sullivan, AbbVie, Arno Therapeutics, BioTie Therapies, Boehringer Ingelheim, Dr. Reddy's Laboratories, Eli Lilly and Company, Genentech, Harvest Moon Pharmaceuticals, Massachusetts General Hospital, Merck, NanoBio Corporation, Novartis, Pfizer, Sanofi, Shire, Takeda Oncology, University of Kentucky, Vical Incorporated

Go to event website